Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,530 | -13,931 | -44,261 | -32,715 | -21,141 |
| Depreciation Amortization | 83 | 32 | 80 | 55 | 37 |
| Income taxes - deferred | -70 | N/A | -618 | N/A | N/A |
| Accounts receivable | -1,114 | N/A | N/A | N/A | N/A |
| Other Working Capital | 46,390 | 47,468 | 3,753 | 4,166 | 1,790 |
| Other Operating Activity | 4,828 | 1,376 | 6,164 | 4,651 | 3,336 |
| Operating Cash Flow | $22,588 | $34,945 | $-34,882 | $-23,842 | $-15,978 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -147 | -35 | -2 |
| Purchase Of Investment | -32,591 | N/A | -7,951 | -7,951 | -7,951 |
| Sale Of Investment | 20,133 | 6,658 | 44,294 | 28,515 | 17,165 |
| Investing Cash Flow | $-12,458 | $6,658 | $36,196 | $20,529 | $9,212 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 748 | 640 | 153 | N/A | N/A |
| Financing Cash Flow | $748 | $640 | $153 | $N/A | $N/A |
| Beginning Cash Position | 28,575 | 28,575 | 27,108 | 27,108 | 27,108 |
| End Cash Position | 39,453 | 70,818 | 28,575 | 23,794 | 20,341 |
| Net Cash Flow | $10,878 | $42,243 | $1,467 | $-3,313 | $-6,766 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,588 | 34,945 | -34,882 | -23,842 | -15,978 |
| Capital Expenditure | N/A | N/A | -147 | -35 | -2 |
| Free Cash Flow | 22,588 | 34,945 | -35,029 | -23,878 | -15,980 |